PubMed دسترسی آزاد

DUET: a graph-based workflow for TCR-epitope prioritization and tumor-reactive T-cell identification.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

Accurate prioritization of T-cell receptor (TCR)-epitope interactions and identification of tumor-reactive T cells are important but difficult steps in immunotherapy-oriented bioinformatics workflows. Existing methods typically address these tasks separately and either model TCR-epitope pairs as independent observations or rely primarily on transcriptomic signatures. In this study, we present DUET (Dual Unified Evaluation of TCR-Epitopes and Tumor-reactive T cells), a graph-based computational workflow that unifies both applications within a single heterogeneous graph framework. The protocol represents TCRs, epitopes, and T cells as typed nodes connected by similarity and association edges, and combines pretrained sequence embeddings with edge-aware graph attention, Laplacian positional encoding, and bidirectional cross-domain attention. Applied to the IEDB and VDJdb benchmarks, DUET achieved AUROC/AUPR values of 0.937/0.922 and 0.992/0.990, respectively, outperforming five state-of-the-art algorithms under standard evaluation. On a single-cell RNA-seq tumor-reactivity benchmark, the workflow achieved an area under the receiver operating characteristic curve of 0.985 and an area under the precision-recall curve of 0.975, substantially exceeding transcriptomic signature-based baselines. Additional generalization analyses showed that DUET's clearest graph-specific benefit occurred under epitope-disjoint TCR-epitope prediction. Ablation analysis showed that Laplacian positional encoding provided the largest performance gain, particularly in sparse graph settings. These results suggest that heterogeneous graph modeling can serve as a practical protocol for integrating receptor sequence, antigen context, and cellular phenotype in computational immunology.

متن کامل اصلی

نسخه دارای مجوز در منبع علمی در دسترس است.

لینک مستقیم از metadata منبع گرفته شده و در تب جدید باز می‌شود.

باز کردن متن کامل

کلیدواژه‌ها

T-cell receptorTCR-epitope bindingheterogeneous graph transformersingle-cell RNA-seqtumor-reactive T cells
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Barry Bloom and the convergence of immunology, infectious disease, and public health.

In early 2026, the world lost Barry Bloom, a great advocate for public health, an extraordinarily accomplished immunologist, and a science advisor who helped refocus policy on controlling infectious diseases, including neglected diseases such as leprosy. Barry's career took him from a life of laboratory discovery where he was enormously influential in catalyzing the late 20th century shift from studying the immune response of simple mo…

PubMed2026

Trajectories in immunometabolism.

Immunometabolism has rapidly evolved from an emerging area within immunology into a topic that not only impregnates most aspects of immune research but also reveals itself as a defining feature of the immune response. At the European Immunometabolism Conference celebrated in June, we asked some of the speakers to share their personal journey as researchers in this field and what questions they are currently working on.

PubMed2026

Hazy mysteries and the major histocompatibility complex: a journey.

I was pleased to receive an invitation to write a historical perspective on my career. As I understand it, these perspectives aim to illustrate the often-twisted paths to discoveries, the fortuitous events that often enable them, and the pitfalls along the way. At the same time, they can be expected to illustrate the influence of the particular "tastes" and interests of a scientist in the choices that are made along the way and that th…